1、 Market strategy: waiting for opportunities after callback
The two markets opened low in the morning, and continued to fall in the afternoon. Technology stocks and white horse stocks continued to weaken, dragging down the index. Yesterday, foreign capital flowed out slightly. Today, because the U.S. stock market was closed, we could not see the flow of funds. But the market trend has explained the attitude of domestic capital. The best way to fail to rise is to take the initiative to step back. Technically, the index has fallen below the 5-day line, and so on the next 4.7 days, the gap was filled
2、 Comments on leading sectors
1. RCS rich media
Leader: Zhongjia Bochuang
The board sector has split today. Yesterday, I said that it is time for the short term to reach the strong and weak knockout competition. Hailian Huijin, Zhongjia Bochuang, and Shenzhou Taiyue continued to play the same role. Samsung Healthcare hit the limit in the afternoon, and Wutong Holding's high position fluctuated. If the front row leaders continue to play the same role next week, Wutong Holding and Huangshi Group still have the opportunity to play the same role. On the contrary, this round of speculation will end
two , Liquor
Leader: Guizhou Moutai
Liquor rose this morning. The recent trend of Guizhou Moutai is good, and it has been on the line for half a year. This should be the result of continued foreign investment buying. The loose global currency has led to a surplus of money. Guizhou Moutai, a large stock, can well absorb this part of the capital and is suitable for tracking the middle line. If it is short, it will not be considered. Most people can't keep it
3. Biomedicine
Leader: Beida Pharmaceutical
Humanwell Pharmaceuticals and Jingfeng Pharmaceuticals opened today, and the short-term popularity leader fell back. On the one hand, Beida Pharmaceuticals, Shanhe Pharmacy and Weiming Pharmaceuticals kept on buying large funds. On the other hand, the fermentation of recent peripheral events will also stimulate related pharmaceutical stocks to continue to strengthen. The former Longtou Weiming Pharmaceuticals will again break through the previous high limit today. If we continue to accelerate the vaccine Biomedicine will continue to accelerate
Live performance review:
March 30: Denghai Seed Industry soared by 10%
